Tempe, AZ, United States of America

Adrian Esqueda

This inventor holds 1 USPTO granted patent. Top assignee: Marv Enterprises, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Esqueda. Retrieved from https://idiyas.com/inventor/adrian-esqueda-9ytarv6s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian Esqueda

Introduction

Adrian Esqueda is a notable inventor based in Tempe, AZ (US). He has made significant strides in the field of medical technology, particularly in the treatment of inflammatory conditions. His work focuses on innovative methods to improve patient outcomes through advanced medical devices.

Latest Patents

Adrian holds a patent for a groundbreaking invention titled "Method, Device, and Product for Treating a Body Fluid of a Patient with an Inflammatory Cytokine Storm by Binding an Antibody to a Cytokine Antigen in the Body Fluid to Form an Antigen-Antibody Complex That Is Removed from the Body Fluid to Reduce the Amount of the Cytokines in the Body Fluid." This patent represents a significant advancement in the treatment of cytokine storms, which can be life-threatening.

Career Highlights

Adrian is currently employed at Marv Enterprises, LLC, where he continues to develop innovative solutions in the medical field. His dedication to research and development has positioned him as a key player in his organization.

Collaborations

Adrian has collaborated with talented individuals such as Collin Bradley Jugler and Mitchell S Felder. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Adrian Esqueda's contributions to medical technology through his patent and work at Marv Enterprises, LLC highlight his commitment to innovation and improving patient care. His efforts are paving the way for future advancements in the treatment of inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…